& Lam, E
However, due to the potency of prescription-grade ingredients like Tretinoin and NAD+, it may not be suitable for: People with rosacea or active eczema/psoriasis flares Those with extremely sensitive or compromised skin barriers Anyone who is pregnant or breastfeeding Individuals allergic to retinoids, copper peptides, or any formula component If you're unsure, we recommend consulting with your provider before beginning use
Doses used in ARA-290 human trials Study context Sarcoidosis pilot (2012) Dose & route 2 mg IV Schedule 3x/week, 4 weeks Study context Sarcoidosis SFN (2013) Dose & route Daily subQ Schedule 28 days Study context Type 2 diabetes neuropathy (2014) Dose & route 4 mg subQ Schedule Daily, 28 days Study context Phase 2b sarcoidosis (2017) Dose & route 1, 4, or 8 mg subQ Schedule Daily, 28 days Study context Diabetic macular edema (2020) Dose & route 4 mg subQ Schedule Daily, 12 weeks This is trial reporting, not a dosing recommendation
Compound Overview BPC-157 (Body Protection Compound-157) is a 15-amino acid peptide sequence derived from a protein found in human gastric juice
Hosted at pedia.peppyandme.com Freely accessible No account required Community Appreciation A thank-you to those who serve